Xishan Biology

News and Information

News Information

Xishan Biology

News and Information

All Years
All Months
condition:
clear condition

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

[Suzhou, May 10, 2025] Recently, our company’s Nano Park facility successfully completed the filing process for its P2 laboratory with the Suzhou Municipal Bureau of Agriculture and Rural Affairs, officially becoming one of the first animal pathogen microbiology laboratories in the entire Suzhou metropolitan area to receive approval under the newly implemented "Jiangsu Province Animal Pathogen Microbiology Laboratory Filing Management Measures" (effective February 1, 2025).

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

Recently, our company successfully passed the on-site expansion review for CMA accreditation, marking official recognition from a national authority of our professional expertise and robust quality management system in the field of laboratory animal testing. The review took place from September 1 to September 2, 2024, during which the expert panel conducted a comprehensive and rigorous assessment of our laboratory animal testing technologies, equipment, personnel, and management systems—ultimately confirming that we meet the relevant CMA standards.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024 – Our company has officially obtained the Veterinary Drug Production License and the Veterinary Drug GMP Certificate issued by the Ministry of Agriculture and Rural Affairs, marking that our company’s quality management system and technical capabilities in the veterinary drug manufacturing sector have met the nation’s stringent high-standard requirements. During this certification process, our immunology-based diagnostic product (Class B) production line successfully passed the on-site GMP inspection for veterinary drugs and was recognized as a qualified production line, laying a solid foundation for the company to further expand into the veterinary diagnostic reagent market.

On March 1, 2024, experts from the Suzhou Municipal Bureau of Agriculture and Rural Affairs visited for an inspection. Our company successfully passed the qualification review for Jiangsu Province's certification as a quarantine and testing laboratory specializing in dogs and cats at their place of origin.

On March 1, 2024, experts from the Suzhou Municipal Bureau of Agriculture and Rural Affairs visited for an inspection. Our company successfully passed the qualification review for Jiangsu Province's certification as a quarantine and testing laboratory specializing in dogs and cats at their place of origin.

[Suzhou, March 1, 2024] Today, a delegation of experts from the Suzhou Municipal Bureau of Agriculture and Rural Affairs visited our company to conduct a comprehensive and meticulous inspection and evaluation of Jiangsu Province’s Canine and Feline Production Quarantine Testing Laboratory. After rigorous review, our laboratory successfully passed the acceptance process, marking another authoritative recognition of the company’s professional expertise and standardized management in the field of animal disease testing.

On August 14, 2023, our company successfully passed the CNAS re-evaluation and on-site assessment for scope expansion.

On August 14, 2023, our company successfully passed the CNAS re-evaluation and on-site assessment for scope expansion.

From August 11 to 13, 2023, a five-member expert team from the China National Accreditation Service for Conformity Assessment (CNAS) conducted a two-day on-site review of our company’s laboratory, including both the re-evaluation and expansion of testing scope. After a rigorous and meticulous assessment, our company successfully passed the review, marking another milestone as we once again receive national-level recognition for our advanced testing capabilities and robust quality management system.

November 15, 2022: Yuan Rijin, Chief Veterinary Physician of the Provincial Department of Agriculture and Rural Affairs, Conducts a Research Visit

November 15, 2022: Yuan Rijin, Chief Veterinary Physician of the Provincial Department of Agriculture and Rural Affairs, Conducts a Research Visit

Yuan Rijin, Chief Veterinary Officer of the Provincial Department of Agriculture and Rural Affairs, Conducts a Research Visit

On June 20, 2023, the Suzhou Municipal Bureau of Agriculture and Rural Affairs and the Municipal Animal Disease Prevention and Control Center conducted a "Biosafety Supervision Review" at our company.

On June 20, 2023, the Suzhou Municipal Bureau of Agriculture and Rural Affairs and the Municipal Animal Disease Prevention and Control Center conducted a "Biosafety Supervision Review" at our company.

To safeguard national security, prevent and address biosecurity risks, protect people's lives and health, conserve biological resources and the ecological environment, promote the healthy development of biotechnology, and foster the building of a community with a shared future for humanity, ensuring harmonious coexistence between humans and nature—on June 17, 2022, the Suzhou Municipal Bureau of Agriculture and Rural Affairs conducted "biosecurity preliminary review" activities at Xishan Biotechnology Co., Ltd. The inspection focused on the company’s work in monitoring animal diseases and conducting epidemiological-related testing projects, as well as its research on animal diseases, parasitic infections, and the detection and analysis of pathogenic microorganisms responsible for contagious animal diseases, alongside evaluations of animal immune antibody levels.

On May 26, 2023, the Jiangsu Provincial Association of Animal Husbandry and Veterinary Medicine conducted a research survey on the "African Swine Fever" project undertaken by our company.

On May 26, 2023, the Jiangsu Provincial Association of Animal Husbandry and Veterinary Medicine conducted a research survey on the "African Swine Fever" project undertaken by our company.

According to the "Animal Epidemic Prevention Law of the People's Republic of China," the "Law of the People's Republic of China on Animal and Plant Quarantine at Entry and Exit," and the "National Emergency Response Plan for Major Animal Disease Outbreaks," this survey was conducted to more effectively prevent African swine fever, firmly safeguard the stable and healthy development of the pig industry, and ensure the safety and supply of pork products.

On November 2, 2022, the Suzhou Municipal Bureau of Agriculture and Rural Affairs conducted a "Special Inspection of Animal Pathogen Microbiology Laboratories" at Suzhou Xishan Technology Co., Ltd.

On November 2, 2022, the Suzhou Municipal Bureau of Agriculture and Rural Affairs conducted a "Special Inspection of Animal Pathogen Microbiology Laboratories" at Suzhou Xishan Technology Co., Ltd.

According to the "Regulations on Biosafety Management of Pathogen Microbiology Laboratories," in order to strengthen biosafety management in pathogen microbiology laboratories and protect the health of laboratory staff and the public, the Suzhou Municipal Bureau of Agriculture and Rural Affairs conducted a special inspection of the "Animal Pathogen Microbiology Laboratory"—a Level 2 biosafety laboratory—at Suzhou Xishan Technology Co., Ltd. on November 2, 2022.

From September 19 to September 21, 2022, the assessment team from the China National Accreditation Service for Conformity Assessment (referred to as CNAS in English) conducted a specialized laboratory supervision review of Suzhou Xishan Biotechnology Co., Ltd.

From September 19 to September 21, 2022, the assessment team from the China National Accreditation Service for Conformity Assessment (referred to as CNAS in English) conducted a specialized laboratory supervision review of Suzhou Xishan Biotechnology Co., Ltd.

To verify the compliance, standardization, and effectiveness of the organization’s testing/calibration/inspection activities, the CNAS assessment team conducted a specialized laboratory oversight review of our company from September 19 to September 21, 2022. This review covered relevant departments, positions, personnel, and activities involved in the operation of the company’s management system, as well as the accredited testing areas. Through on-site inspections and by examining reports, records, and archives, the assessment team thoroughly evaluated the effectiveness, compliance, and adaptability of our company’s management system.

< 12 >